eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Review paper

IMPORTANCE OF PLANTAGO OVATA SEED HUSK (PSYLLIUM HUSK) IN THE PREVENTION AND NON-PHARMACOLOGICAL TREATMENT OF HYPERCHOLESTEROLEMIA, POSTPRANDIAL HYPERGLYCEMIA AND HYPERTENSION

Justyna Przybyszewska
1
,
Andrzej Kuźmiński
1, 2
,
Michał Przybyszewski
3

  1. Department of Nutrition and Dietetics, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
  2. Department of Allergology, Clinical Immunology and Internal Diseases, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
  3. Clinical Immunology and Internal Diseases Department, Jan Biziel University Hospital No. 2, Bydgoszcz, Poland
Health Prob Civil.
DOI: https://doi.org/10.5114/hpc.2024.142911
Online publish date: 2024/09/20
Article file
- Przybyszewska et al.pdf  [0.92 MB]
Get citation
 
PlumX metrics:
 
1. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Rev Esp Cardiol (Engl Ed). 2022; 75(5): 429. https://doi.org/10.1016/j.rec.2022.04.003
2. World Health Organization. Disease burden and mortality estimates [Internet]. Geneva: WHO [access 2021 Jun 4]. Available from: www.who.int/healthinfo/global_burden_disease/estimates/en
3. Singh B. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007; 334(1-2): 1-14. https://doi.org/10.1016/j.ijpharm.2007.01.028
4. Chen C, Shang C, Xin L, Xiang M, Wang Y, Shen Z, et al. Beneficial effects of psyllium on the prevention and treatment of cardiometabolic diseases. Food Funct. 2022; 13(14): 7473-7486. https://doi.org/10.1039/d2fo00560c
5. US Food and Drug Administration. Press Release P04-100. Silver Spring: FDA; 2004.
6. Santos R, Melo N, Sanches-Silva A. Psyllium (Plantago ovata Forsk): from evidence of health benefits to its food application. Trends Food Sci. Technol. 2020; 96: 166-175. https://doi.org/10.1016/j.tifs.2019.12.006
7. McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet. 2017; 117(2): 251-264. https://doi.org/10.1016/j.jand.2016.09.021
8. Food and Drug Administration. Food labeling: health claims; soluble fiber from certain foods and coronary heart disease. Federal Register, Vol. 63, No. 32 [Internet]. Silver Spring: FDA; 1998 Feb 18 [access 2021 March 15]. Available from: https://www.govinfo.gov/content/pkg/FR-1998-02-18/pdf/98-4074.pdf
9. McRorie JW Jr, Gibb RD, Womack JB, Daniel J. Psyllium is superior to wheat dextrin for lowering elevated serum cholesterol. Nutrition Today. 2017; 52(6): 289-294. https://doi.org/10.1097/NT.0000000000000243.
10. Jovanovski E, Yashpal S, Komishon A, Zurbau A, Blanco Mejia S, Ho HVT, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2018; 108(5): 922-932. https://doi.org/10.1093/ajcn/nqy115
11. Brum J, Ramsey D, McRorie J, Bauer B, Kopecky SL. Meta-Analysis of usefulness of psyllium fiber as adjuvant antilipid therapy to enhance cholesterol lowering efficacy of statins. Am J Cardiol. 2018; 122(7): 1169-1174. https://doi.org/10.1016/j.amjcard.2018.06.040
12. Lambeau KV, McRorie JW Jr. Fiber supplements and clinically proven health benefits: How to recognize and recommend an effective fiber therapy. J Am Assoc Nurse Pract. 2017; 29(4): 216-223. https://doi.org/10.1002/2327-6924.12447
13. McRorie JW Jr. Psyllium is not fermented in the human gut. Neurogastroenterol Motil. 2015; 27(11): 1681-1682. https://doi.org/10.1111/nmo.12649
14. McRorie J. Clinical data support that psyllium is not fermented in the gut. Am J Gastroenterol. 2013; 108(9): 1541. https://doi.org/10.1038/ajg.2013.211
15. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V, et al. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr. 2010; 92(4): 723-732. https://doi.org/10.3945/ajcn.2010.29174
16. Noureddin S, Mohsen J, Payman A. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: a randomized trial in patients with type 2 diabetes and chronic constipation. Complement Ther Med. 2018; 40: 1-7. https://doi.org/10.1016/j.ctim.2018.07.004
17. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J. 1978; 1(6124): 1392-1394. https://doi.org/10.1136/bmj.1.6124.1392
18. Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr. 2015; 102(6): 1604-1614. https://doi.org/10.3945/ajcn.115.106989.
19. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393-403. https://doi.org/10.1056/NEJMoa012512
20. Rodríguez-Morán M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications. 1998; 12(5): 273-278. https://doi.org/10.1016/s1056-8727(98)00003-8
21. Díez R, García JJ, Diez MJ, Sierra M, Sahagun AM, Fernández N. Influence of Plantago ovata husk (dietary fiber) on the bioavailability and other pharmacokinetic parameters of metformin in diabetic rabbits. BMC Complement Altern Med. 2017; 17(1): 298. https://doi.org/10.1186/s12906-017-1809-x
22. Fernandez-Martinez MN, Hernandez-Echevarria L, Sierra-Vega M, Diez-Liebana MJ, Calle-Pardo A, Carriedo-Ule D, et al. A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters. BMC Complement Altern Med. 2014; 14: 296. https://doi.org/10.1186/1472-6882-14-296
23. Karhunen LJ, Juvonen KR, Flander SM, Liukkonen KH, Lähteenmäki L, Siloaho M, et al. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr. 2010; 140(4): 737-744. https://doi.org/10.3945/jn.109.115436
24. Khan K, Jovanovski E, Ho HVT, Marques ACR, Zurbau A, Mejia SB, et al. The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2018; 28(1): 3-13. https://doi.org/10.1016/j.numecd.2017.09.007
25. Fu YS, Lue SI, Lin SY, Luo CL, Chou CC, Weng CF. Plantago asiatica seed extracts alleviated blood pressure in phase i⁻spontaneous hypertension rats. Molecules. 2019; 24(9): 1734. https://doi.org/10.3390/molecules24091734
26. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007; 29(6): 383-394. https://doi.org/10.1080/10641960701578378
27. Murad S, Waseem R, Bashir A, Ashraf HH, Sheikh RA. Keep heart healthy by normalising body weight, blood pressure and weight reduction. Pakistan J. Medical Health Sci. 2011; 5: 228-231.
28. Clark CCT, Salek M, Aghabagheri E, Jafarnejad S. The effect of psyllium supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Korean J Intern Med. 2020; 35(6): 1385-1399. https://doi.org/10.3904/kjim.2019.049
29. McRorie JW, Gibb RD, Sloan KJ, McKeown NM. Psyllium: the gel-forming nonfermented isolated fiber that delivers multiple fiber-related health benefits. Nutrition Today. 2021; 56(4): 169-182. https://doi.org/10.1097/NT.0000000000000489
30. Jalanka J, Major G, Murray K, Singh G, Nowak A, Kurtz C, et al. The effect of psyllium husk on intestinal microbiota in constipated patients and healthy controls. Int J Mol Sci. 2019; 20(2): 433. https://doi.org/10.3390/ijms20020433
31. Cremon C, Barbaro MR, Ventura M, Barbara G. Pre- and probiotic overview. Curr Opin Pharmacol. 2018; 43: 87-92. https://doi.org/10.1016/j.coph.2018.08.010
32. US Food and Drug Administration. Petitions for health claims. Code of Federal Regulations. Title 21, Volume 2. CFR §101.70 [Internet]. Silver Spring: FDA; 2019 Nov 26 [access 2022 Nov 22]. Available from: https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=fcbd248e14301 836124846a29f95de47&mc=true&n=pt21.2.101&r=PART&ty=HTML#se21.2.101_170
33. Drug Monograph. Psyllium [Internet]. Elsevier [access 2023 Jan 06]. Available from: https://www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-527
34. Belorio M, Gómez M. Psyllium: a useful functional ingredient in food systems. Crit Rev Food Sci Nutr. 2022; 62(2): 527-538. https://doi.org/10.1080/10408398.2020.1822276
35. Lantner RR, Espiritu BR, Zumerchik P, Tobin MC. Anaphylaxis following ingestion of a psyllium-containing cereal. JAMA. 1990; 264(19): 2534-2536.
36. Khalili B, Bardana EJ Jr, Yunginger JW. Psyllium-associated anaphylaxis and death: a case report and review of the literature. Ann Allergy Asthma Immunol. 2003; 91(6): 579-584. https://doi.org/10.1016/S1081-1206(10)61538-4
37. Solà R, Godàs G, Ribalta J, Vallvé JC, Girona J, Anguera A, et al. Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am J Clin Nutr. 2007; 85(4): 1157-63. https://doi.org/10.1093/ajcn/85.4.1157
38. Sierra M, García JJ, Fernández N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002; 56(9): 830-842. https://doi.org/10.1038/sj.ejcn.1601398.8
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.